International Journal of Hematology

DOI: 10.1007/s12185-018-02564-z Pages: 241-241

Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

1. St. Marianna University School of Medicine Yokohama City Seibu Hospital, Department of Pediatrics

2. Tokyo Medical University Hospital, Department of Laboratory Medicine

3. Nagoya University Hospital, Department of Transfusion Medicine

4. Nara Medical University, Department of Pediatrics

5. Japanese Red Cross Society Tokai-Hokuriku Block Blood Center

6. Shire, Department of Medical Affairs

7. Shire, Department of Clinical Scientific Writing

8. Shire, Department of Biostatistics

9. Kitakyushu Yahatahigashi Hospital

Correspondence to:
Masashi Taki



The authors would like to correct the errors in the publication of the original article. The correction details are given below:

This article is freely available, click here to access the full text/PDF

Share the Knowledge